International Pharmaceutical News for China digital issue - August 2020
What's new in this issue?
Ringier Trade Media Ltd
Click here to read International Pharmaceutical News for China
Click here to read International Pharmaceutical News for China

Scan this QR Code and get access to 600+ FREE Digital Magazine issues

Please forward this email to your colleagues so they can benefit from the content!

International Pharmaceutical News for China

Your digital edition has arrived - So much more than a magazine!

To read the August 2020 issue, click here.

Our E-Zine is now available for all devices.
You can download our APPs- industry sourcing, for iOS and Android.

This Month's Features include:

Mayo Clinic during COVID-19: Combine clinical practice with scientific research

High-Throughput Screening For The Discovery of Enzyme Inhibitors

A Glass Full of Hope

Link to: Video   Webinar   Supplier Article  Advertiser's Product Index

Advertisement deaWdline of next issue: 10 September 2020

Coming up in the next issue:
1. Outlook

>> Contact us Now!

We hope you enjoy the new digital edition of International Pharmaceutical News for China! If you have any questions or would like to receive a print edition, please contact our Circulation Department via email at circ@ringiertrade.com.

For Advertising Inquiries, please contact Mike Hay at mchhay@ringier.com.hk.

To download the media kit 2020 click here or contact crm@ringiertrade.com

Best Regards,
Amy Shen
Circulation Manager
Ringier Trade Media Limited

This email was sent to [EMAIL] by Ringier Trade Media Ltd. © 2020 | Industrysourcing.com © 2020
Unit 20B, 20/F., 235 Wing Lok Street Trade Centre, 235 Wing Lok Street, Sheung Wan, Hong Kong
Unsubscribe | Privacy Policy | Change your Email
Please add Newsletter@ringiermail.com to your mail safelist (whitelist) to ensure our emails reach your inbox. You are receiving this email as an Industrysourcing.com subscriber or registered website user, relevant trade show attendee or industry professional.
For more information on cooperation, please contact us 800-820-0083